Lebrikizumab Delivers Clinically Meaningful and Continuous Improvement in Itch-Free Days in Atopic Dermatitis Through One Year. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s273. https://doi.org/10.25251/skin.7.supp.273